bakfs2016_6k.htm - Generated by SEC Publisher for SEC Filing
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934


For the month of August, 2017

(Commission File No. 1-14862 )

 

 
BRASKEM S.A.
(Exact Name as Specified in its Charter)
 
N/A
(Translation of registrant's name into English)
 


Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)



Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.


 
 

 

                                                 

 

 

 

 

Braskem S.A.

Financial Statements

at December 31, 2016

and Independent Auditors' Report

 

 

 

 

 


 
 

 

KPMG Auditores Independentes

Rua Arquiteto Olavo Redig de Campos, 105, 6º andar - Torre A

04711-904 - São Paulo/SP - Brasil

Caixa Postal 79518 - CEP 04707-970 - São Paulo/SP - Brasil

Telefone +55 (11) 3940-1500, Fax +55 (11) 3940-1501

www.kpmg.com.br

                       

 

Independent Auditor’s Report in the Individual and Consolidated Financial Statements

 

To Shareholders, Members of the Board and Management

Braskem S.A.

Camaçari - Bahia

 

Opinion

We have audited the individual and consolidated financial statements of Braskem S.A. (“the Company”), respectively referred to as Parent and Consolidated, which comprise the statement of financial position as at December 31, 2016, the statements of profit or loss and other comprehensive income, changes in equity and cash flows for the year then ended, and notes, comprising significant accounting policies and other explanatory information.

 

Opinion on the individual financial statements

In our opinion, the accompanying individual financial statements present fairly, in all material respects, the financial position of the Braskem S.A. (“the Company”) as at December 31, 2016, and of its financial performance and its cash flows for the year then ended in accordance with Accounting Practices Adopted in Brazil.

 

Opinion on the consolidated financial statements

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Braskem S.A. as at December 31, 2016, and of its consolidated financial performance and its cash flows for the year then ended in accordance with Accounting Practices Adopted in Brazil and with International Financial Reporting Standards (IFRS), issued by the International Accounting Standards Board (IASB).

 

Basis for Opinion

We conducted our audit in accordance with Brazilian and International Standards on Auditing. Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Individual and Consolidated Financial Statements section of our report. We are independent of the Company and its subsidiaries in accordance with the relevant ethical requirements included in the Accountant Professional Code of Ethics (“Código de Ética Profissional do Contador”) and in the professional standards issued by the Brazilian Federal Accounting Council (“Conselho Federal de Contabilidade”) and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

 


 
 

 

Emphasis of a matter

We call your attention to note 23.3, which says that, in the ambit of Lava Jato operation investigations, existence of undue payments by the Company were confirmed from 2006 to 2014 as services provided by third-parties with no proof of effective rendering of services. Such note also says that the Company entered into a Leniency Agreement (the “Agreement”) with the Federal Prosecution Office, the Department of Justice (DoJ) and the Securities and Exchange Commission (SEC) of the United States of America, and with the General Prosecution Office of Switzerland, in the approximate amount of R$3.1 billion, and discloses information on progress of class action brought in the United States of America. Except for the value of the Agreement, as well as other non-monetary penalties enforced, the Company is not able, for the moment, to reliably foresee or measure the extent of financial and non-financial impacts on the Company and, accordingly, is not able to record possible additional losses that confirmation of accusations, possible lawsuits filed by other authorities and/or third-parties, and parallel investigations could cause to the Company, as well as resources required to remedy such occurrences, including possible effects deriving from the outcome of above-mentioned class action. Our opinion is not qualified in relation to this matter.

 

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the individual and consolidated financial statements of the current period. These matters were addressed in the context of our audit of the individual and consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

 

Contingencies and disputes – note 23.3 (individual and consolidated)

 

As explained in note 23.3 to individual and consolidated financial statements, in the ambit of “Lava Jato” operation of the Brazilian Federal Police, the Company was mentioned in testimonies of witnesses with immunity as involved in undue payments made for services provided by third-parties, with no proof of effective rendering. In view of such events, the Company made necessary arrangements, including internal investigation conducted with the aid of independent office specialized in investigations, dialogue with competent Brazilian and international authorities, and follow-up of progress of class action brought in the United States of America. As a result of dialogues and discussions around this theme with competent authorities, including the USA Department of Justice (DOJ) and Securities and Exchange Commission (SEC), and the Brazilian Public Prosecution Office, the Company entered into a Leniency Agreement and committed to paying the amount of approximately R$3.1 billion as fine and indemnity, which was recorded in financial statements as of December 31, 2016. In addition, the Company paid taxes for prior years referring to outsourced services, with no proof of effective rendering of services. These taxes were retrospectively recorded at their proper periods. Given the complexity of the matter, relevance of impacts and disclosures in financial statements and involved decisions, we considered this matter as significant for our audit.

 

How our audit conducted this issue

Main procedures conducted by us are as follows:

  • Discussion with the executive office, Tax Council and Board of Directors about scope and results of internal investigations conducted by the Company.

 


 
 

 

  • Involvement of our forensic investigation specialists to evaluate scope and methodology used for internal investigation, follow up work conducted by the Company’s external legal advisors, conduct interviews with the Company’s main executives, and determine other procedures considered as necessary under work circumstances.
  • Procedures for analysis of transaction documents related to the theme, including, among others, purchases of raw material (Nafta), expenses with services and payments without effective proof of service rendering, which were identified by the law firm responsible for investigations.
  • Recalculation, with the aid of our tax specialists, of tax effects deriving from payments referring to services without effective proof of rendering.
  • Obtaining specific representations of executive board, Tax Council, and Board of Directors.
  • Evaluation of disclosures related to this theme in the financial statements.

 

 

Intangible assets recoverable value with undefined useful life (goodwill) and deferred tax assets – notes 14(a) and 20.2 (individual and consolidated)

 

The Company maintains a significant balance of intangible assets with undefined useful lives (goodwill) and deferred tax assets, whose recoverability is based on cash flow analyses and projections, and income generation. Due to uncertainties inherent to the process of determining future cash flows and some assumptions - such as discount rates, which are the basis for evaluation of recoverable value of such assets -, we considered this matter as significant for our audit.

 

How our audit conducted this issue

We understood the process and evaluated the design and implementation of internal controls related to the preparation and review of the business plan, budgets and impairment analysis provided by the Company. We can count with the help of our specialists in corporate finance to evaluate assumptions and methodologies, such as discount rate based on average capital cost (WAAC), growth rate for the next 5 years, expected sales volume and margin, among others, used by the Company to project cash flow. We also evaluated disclosures made by the Company, mainly those related to sensitivity analysis, which demonstrate the impact on recoverable value resulting from possible and reasonable changes in key assumptions used by the Company.

 

 

Fair value of financial instruments – notes 4 and 17 (individual and consolidated)

 

In view of relevance and complexity of estimates made to measure fair value of financial instruments and possible impact that changes in pricing assumptions and techniques used to measure such value would have on the Company’s income and financial position, and also considering that the Company adopts hedge accounting, we consider this as a significant matter for our audit.

 

How our audit conducted this issue

We understood the process and evaluated design and implementation of internal controls related to the process of evaluating financial instruments. Our audit work also included tests on samples of transactions with these financial instruments and, with the involvement of our specialists in financial instruments, we recalculated them based on pricing methodologies and data and information sources independently defined, and compared our results with those recorded by the Company. We evaluated effectiveness of hedge accounting calculation and also evaluated adequacy of disclosures made by the Company involving transactions with financial instruments and hedge accounting, mainly those related to sensitivity analysis of these instruments.

 


 
 

 

Other matters

 

Statements of value added

The individual and consolidated statements of value added (DVA) for the year ended December 31, 2016, prepared under the responsibility of the Company’s management, and presented herein as supplementary information for IFRS purposes, have been subject to audit procedures jointly performed with the audit of the Company's financial statements.  In order to form our opinion, we assessed whether those statements are reconciled with the financial statements and accounting records, as applicable, and whether their format and contents are in accordance with criteria determined in the Technical Pronouncement 09 (CPC 09) - Statement of Value Added issued by the Committee for Accounting Pronouncements (CPC). In our opinion, the statements of value added have been fairly prepared, in all material respects, in accordance with the criteria determined by the aforementioned Technical Pronouncement, and are consistent with the overall individual and consolidated financial statements.

 

Audit of the corresponding amounts

The examination of the individual and consolidated balance sheet on January 1, 2015 (derived from the financial statements for the year ended December 31, 2014), originally prepared prior to the adjustments described in Note 2.4, was conducted under the responsibility of other independent auditors, who issued an audit report without changes dated February 12, 2015. As part of our analysis of the financial statements for the year ended December 31, 2016, we examined the adjustments in the corresponding amounts of the balance sheets on January 1, 2015 and, in our opinion, are appropriate and have been properly carried out, in all material respects. We were not hired to audit, review or apply any other procedures in regard to the information related to the balance sheets as of January 1, 2015 and, accordingly, we did not express an opinion or any type of assurance taken as a whole.

 

Other information accompanying the individual and consolidated financial statements and the auditor's report

 

Management is responsible for the other information comprising the management report.

Our opinion on the individual and consolidated financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

 

In connection with our audit of the individual and consolidated financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the individual and consolidated financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

Responsibilities of Management and Those Charged with Governance for the Individual and Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the individual and consolidated financial statements in accordance with Accounting Practices Adopted in Brazil and with International Financial Reporting Standards (IFRS), issued by the International Accounting Standards Board (IASB) and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 


 
 

 

In preparing the individual and consolidated financial statements, management is responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company and subsidiaries or to cease operations, or has no realistic alternative but to do so.

 

Those charged with governance are responsible for overseeing the Company’s and subsidiaries financial reporting process.

 

Auditors’ Responsibilities for the Audit of the Individual and Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the individual and consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with Brazilian and international standards on auditing will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

As part of an audit in accordance with Brazilian and international standards on auditing, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

 

  • Identify and assess the risks of material misstatement of the individual and consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
  • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s and its subsidiaries internal control.
  • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
  • Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s and its subsidiaries ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the individual and consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause the Company and subsidiaries to cease to continue as a going concern.

 

 


 
 

 

  • Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the individual and consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
  • Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Group to express an opinion on the individual and consolidated financial statements.  We are responsible for the direction, supervision and performance of the group audit.  We remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

 

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

 

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the individual and consolidated financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditors’ report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

 

 

São Paulo, August 15, 2017

 

 

KPMG Auditores Independentes

CRC 2SP014428/O-6

 

Original report in Portuguese signed by

Anselmo Neves Macedo

Accountant CRC 1SP160482/O-6

 

 


 
 

Braskem S.A.

 

Balance sheet at December 31

All amounts in thousands of reais                                                                                                                                                                                   

 
       

Consolidated

 

Parent company

Assets

Note

 

2016

 

2015

 

1/1/2015

 

2016

 

2015

 

1/1/2015

   

2.4

     

Restated

 

Restated

     

Restated

 

Restated

Current assets

 

                       
 

Cash and cash equivalents

6

 

6,701,864

 

7,043,262

 

3,891,271

 

3,561,431

 

4,415,764

 

2,325,638

 

Financial investments

7

 

1,190,483

 

414,893

 

194,431

 

741,086

 

358,659

 

168,893

 

Trade accounts receivable

8

 

1,634,137

 

2,755,708

 

2,409,146

 

952,689

 

2,454,015

 

5,132,395

 

Inventories

9

 

5,238,014

 

6,108,697

 

5,619,322

 

3,795,899

 

4,749,972

 

4,027,395

 

Taxes recoverable

11

 

826,015

 

1,312,341

 

2,152,121

 

543,275

 

762,824

 

1,416,523

 

Dividends and interest on capital

10

 

14,986

 

1,998

 

 

 

31,421

 

87,655

 

69,955

 

Prepaid expenses

 

 

101,747

 

166,170

 

99,469

 

83,252

 

139,668

 

72,997

 

Related parties

10

 

 

 

10,507

 

66,616

 

172,344

 

118,661

 

132,413

 

Derivatives operations

17.3

 

8,387

 

53,662

 

33,555

 

8,387

 

12,616

 

33,555

 

Other receivables

 

 

180,915

 

272,530

 

282,213

 

128,231

 

248,488

 

201,025

   

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

15,896,548

 

18,139,768

 

14,748,144

 

10,018,015

 

13,348,322

 

13,580,789

   

 

                       

Non-current assets held for sale

5

 

359,704

 

 

 

 

 

263,912

 

 

 

 

   

 

                       
   

 

 

16,256,252

 

18,139,768

 

14,748,144

 

10,281,927

 

13,348,322

 

13,580,789

Non-current assets

 

                       
 

Financial investments

7

 

 

 

46,193

 

42,494

 

 

 

46,193

 

42,495

 

Trade accounts receivable

8

 

70,236

 

19,822

 

25,050

 

2,794,889

 

4,279,433

 

23,129

 

Advances to suppliers

9

 

61,533

 

135,046

 

68,988

 

61,533

 

135,046

 

68,988

 

Taxes recoverable

11

 

1,088,353

 

1,317,760

 

1,059,132

 

998,039

 

1,212,005

 

976,255

 

Deferred income tax and social contribution

20(c)

 

1,653,115

 

3,204,666

 

886,081

 

42,459

 

2,157,513

 

489,953

 

Judicial deposits

 

 

233,320

 

277,093

 

230,945

 

226,894

 

268,572

 

223,940

 

Related parties

10

 

 

 

144,633

 

138,501

 

14,472

 

124,645

 

137,477

 

Insurance claims

 

 

50,653

 

63,199

 

143,932

 

50,653

 

60,778

 

139,751

 

Derivatives operations

17.3

 

29,308

 

12,280

 

39,350

 

 

 

 

 

 

 

Other receivables

 

 

140,971

 

192,193

 

86,024

 

129,704

 

125,898

 

47,575

 

Investments in subsidiaries and jointly-controlled investments

12

 

92,313

 

86,354

 

126,535

 

4,132,529

 

4,499,871

 

4,668,625

 

Property, plant and equipment

13

 

29,336,710

 

34,100,289

 

29,070,958

 

15,963,127

 

16,542,078

 

17,297,907

 

Intangible assets

14

 

2,809,087

 

2,887,604

 

2,835,728

 

2,521,243

 

2,572,341

 

2,610,027

   

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

35,565,599

 

42,487,132

 

34,753,718

 

26,935,542

 

32,024,373

 

26,726,122

   

 

                       

Total assets

0

 

51,821,851

 

60,626,900

 

49,501,862

 

37,217,469

 

45,372,695

 

40,306,911

 

 

 

The Management notes are an integral part of the financial statements.

 

1

 


 
 

Braskem S.A.

 

Balance sheet at December 31

All amounts in thousands of reais

Continued

 

       

Consolidated

 

Parent company

Liabilities and shareholders' equity

Note

 

2016

 

2015

 

1/1/2015

 

2016

 

2015

 

1/1/2015

   

2.4

     

Restated

 

Restated

     

Restated

 

Restated

Current liabilities

 

                       
 

Trade payables

 

 

6,545,136

 

12,373,555

 

10,839,875

 

2,056,661

 

10,157,223

 

10,443,712

 

Borrowings

15

 

2,594,463

 

1,969,993

 

1,419,470

 

2,117,409

 

2,567,124

 

2,134,951

 

Braskem Idesa borrowings

16

 

10,437,791

 

302,266

 

26,462

 

 

 

 

 

 

 

Derivatives operations

17.3

 

29,042

 

57,760

 

95,626

 

 

 

8,351

 

18,588

 

Payroll and related charges

 

 

562,455

 

610,286

 

533,373

 

431,688

 

446,125

 

412,890

 

Taxes payable

18

 

624,080

 

1,003,273

 

233,434

 

424,088

 

507,758

 

147,025

 

Dividends

26(b)

 

3,083

 

753,668

 

215,888

 

3,083

 

753,668

 

218,664

 

Advances from customers

21

 

203,216

 

119,680

 

99,750

 

28,200

 

44,528

 

45,887

 

Leniency agreement

23.3 and 30

 

1,354,492

 

 

 

 

 

948,286

 

 

 

 

 

Sundry provisions

22

 

112,891

 

93,942

 

88,547

 

87,084

 

67,190

 

53,049

 

Post-employment benefits

24.2.3

 

 

 

 

 

336,357

 

 

 

 

 

336,357

 

Accounts payable to related parties

10

 

 

 

 

 

 

 

956,609

 

4,297,735

 

447,357

 

Other payables

25

 

476,262

 

358,572

 

197,808

 

295,233

 

207,730

 

110,814

   

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

22,942,911

 

17,642,995

 

14,086,590

 

7,348,341

 

19,057,432

 

14,369,294

   

 

                       

Non-current liabilities held for sale

5

 

95,396

 

 

 

 

 

 

 

 

 

 

   

 

                     
   

 

 

23,038,307

 

17,642,995

 

14,086,590

 

7,348,341

 

19,057,432

 

14,369,294

Non-current liabilities

 

                       
 

Trade payables

 

 

201,686

 

57,148

 

 

 

8,832,553

 

3,420,281

 

 

 

Borrowings

15

 

20,736,604

 

25,380,518

 

18,926,729

 

6,463,032

 

8,207,012

 

7,863,666

 

Braskem Idesa borrowings

16

 

 

 

11,975,167

 

7,551,033

 

 

 

 

 

 

 

Derivatives operations

17.3

 

861,302

 

1,119,741

 

594,383

 

861,302

 

1,119,741

 

594,383

 

Taxes payable

18

 

24,097

 

26,716

 

260,010

 

23,830

 

25,825

 

259,945

 

Accounts payable to related parties

10

 

 

 

 

 

 

 

8,234,053

 

10,905,207

 

10,008,077

 

Loan to non-controlling shareholders of Braskem Idesa

19

 

1,620,519

 

1,538,784

 

792,188

 

 

 

 

 

 

 

Deferred income tax and social contribution

20(c)

 

510,523

 

772,828

 

627,011

 

 

 

 

 

 

 

Post-employment benefits

24.2

 

162,136

 

170,237

 

114,478

 

71,899

 

69,696

 

45,302

 

Provision for losses on subsidiaries

 

 

 

 

 

 

 

 

92,365

 

137,013

 

654,766

 

Advances from customers

21

 

162,955

 

31,116

 

88,402

 

 

 

12,813

 

26,147

 

Contingencies

23

 

985,237

 

554,481

 

408,711

 

926,819

 

501,293

 

362,733

 

Leniency agreement

23.3 and 30

 

1,498,738

 

 

 

 

 

1,400,224

 

 

 

 

 

Sundry provisions

22

 

206,245

 

99,491

 

96,966

 

169,499

 

70,056

 

77,182

 

Other payables

25

 

92,792

 

312,189

 

358,303

 

6,070

 

167,060

 

254,933

       

 

 

 

 

 

 

 

 

 

 

 

       

27,062,834

 

42,038,416

 

29,818,214

 

27,081,646

 

24,635,997

 

20,147,134

   

 

                       

Shareholders' equity

26

                       
 

Capital

 

 

8,043,222

 

8,043,222

 

8,043,222

 

8,043,222

 

8,043,222

 

8,043,222

 

Capital reserve

   

232,430

 

232,430

 

232,430

 

232,430

 

232,430

 

232,430

 

Revenue reserves

 

 

834,616

 

2,882,019

 

736,180

 

834,616

 

2,882,019

 

736,180

 

Other comprehensive income

 

 

(6,321,859)

 

(9,060,710)

 

(2,943,172)

 

(6,321,859)

 

(9,060,710)

 

(2,943,172)

 

Treasury shares

 

 

(49,819)

 

(49,819)

 

(48,892)

 

(927)

 

(927)

 

 

 

Accumulated losses

 

 

 

 

(416,768)

 

(278,177)

 

 

 

(416,768)

 

(278,177)

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total attributable to the Company's shareholders

 

 

2,738,590

 

1,630,374

 

5,741,591

 

2,787,482

 

1,679,266

 

5,790,483

   

 

                       
 

Non-controlling interest in Braskem Idesa

 

 

(1,017,880)

 

(684,885)

 

(144,533)

 

 

 

 

 

 

   

 

                       
   

 

 

1,720,710

 

945,489

 

5,597,058

 

2,787,482

 

1,679,266

 

5,790,483

   

 

                       

Total liabilities and shareholders' equity

 

 

51,821,851

 

60,626,900

 

49,501,862

 

37,217,469

 

45,372,695

 

40,306,911

                             

 

                                                                 

 

The Management notes are an integral part of the financial statements.

 

2

 


 
 

Braskem S.A.

 

Statement of operations

Years ended December 31

All amounts in thousands of reais

 

         

Consolidated

 

Parent company

     

Note

 

2016

 

2015

 

2016

 

2015

Continued operations

 

2.4

     

Restated

     

Restated

Net sales revenue

 

28

 

47,663,988

 

46,879,989

 

35,178,466

 

33,583,599

 

Cost of products sold

 

 

 

(34,940,619)

 

(36,728,023)

 

(27,095,009)

 

(25,860,037)

     

 

               
     

 

 

12,723,369

 

10,151,966

 

8,083,457

 

7,723,562

     

 

               

Income (expenses)

 

 

               
 

Selling and distribution

 

 

 

(1,410,828)

 

(1,083,156)

 

(972,394)

 

(813,888)

 

General and administrative

 

 

 

(1,477,199)

 

(1,280,470)

 

(824,573)

 

(868,057)

 

Research and development

 

 

 

(162,010)

 

(169,635)

 

(104,832)

 

(110,583)

 

Results from equity investments

 

12(c)

 

30,078

 

2,219

 

955,535

 

617,744

 

Other income (expenses), net

 

30

 

(3,752,163)

 

(731,204)

 

(3,039,575)

 

(308,129)

     

 

               
     

 

 

5,951,247

 

6,889,720

 

4,097,618

 

6,240,649

     

 

               

Financial results

 

31

               
 

Financial expenses

 

 

 

(3,570,962)

 

(3,163,402)

 

(2,847,039)

 

(3,038,547)

 

Financial income

 

 

 

690,122

 

584,933

 

632,452

 

425,868

 

Exchange rate variations, net

 

 

 

(3,210,417)

 

102,910

 

(2,054,042)

 

757,658

     

 

               
     

 

 

(6,091,257)

 

(2,475,559)

 

(4,268,629)

 

(1,855,021)

     

 

               

Profit before income tax and social contribution

 

 

 

(140,010)

 

4,414,161

 

(171,011)

 

4,385,628

     

 

               
 

Current and deferred income tax and social contribution

 

20(a)

 

(616,046)

 

(1,660,354)

 

(271,419)

 

(1,385,796)

     

 

               

Profit (loss) for the year of continued operations

 

 

 

(756,056)

 

2,753,807

 

(442,430)

 

2,999,832

     

 

               

Discontinued operations results

 

 

               
 

Profit from discontinued operations

 

 

 

40,760

 

16,827

 

30,958

 

1,888

 

Current and deferred income tax and social contribution

 

 

 

(13,901)

 

(10,445)

 

 

 

 

     

 

 

26,859

 

6,382

 

30,958

 

1,888

     

 

               

Profit (loss) for the year

 

 

 

(729,197)

 

2,760,189

 

(411,472)

 

3,001,720

     

 

               

Attributable to:

 

 

               
 

Company's shareholders

 

 

 

(411,472)

 

3,001,720

 

 

 

 

 

Non-controlling interest in Braskem Idesa

 

 

 

(317,725)

 

(241,531)

       
     

 

               

Profit (loss) for the year

 

 

 

(729,197)

 

2,760,189

       

 

The Management notes are an integral part of the financial statements.

 

3

 


 
 

Braskem S.A.

 

Statement of comprehensive income

Years ended December 31

All amounts in thousands of reais, except earnings (loss) per share

 

         

Consolidated

 

Parent company

     

Note

 

2016

 

2015

 

2016

 

2015

     

2.4

     

Restated

     

Restated

Profit (loss) for the year

 

 

 

(729,197)

 

2,760,189

 

(411,472)

 

3,001,720

     

 

               

Other comprehensive income or loss:

 

 

               

Items that will be reclassified subsequently to profit or loss

 

 

               
 

Fair value of cash flow hedge

 

 

 

215,510

 

(621,991)

 

266,995

 

(522,825)

 

Income tax and social contribution

 

 

 

(75,333)

 

206,315

 

(90,778)

 

177,760

 

Fair value of cash flow hedge - Braskem Idesa

 

 

 

 

 

 

 

(38,614)

 

(74,375)

 

Income tax and social contribution

 

 

 

 

 

 

 

11,584

 

21,416

 

Fair value of cash flow hedge from jointly-controlled

 

 

 

(3,309)

 

2,295

 

(3,309)

 

2,295

     

 

 

136,868

 

(413,381)

 

145,878

 

(395,729)

     

 

               
 

Exchange variation of foreign sales hedge

 

17.4(a.i)

 

4,121,849

 

(8,437,079)

 

4,121,849

 

(8,437,079)

 

Sales Hedge - transfer to profit or loss

 

17.4(a.i)

 

1,297,910

 

 

 

1,297,910

 

 

 

Income tax and social contribution on exchange variation

 

 

 

(1,842,718)

 

2,868,607

 

(1,842,718)

 

2,868,607

 

Exchange variation of foreign sales hedge - Braskem Idesa

 

17.4(a.ii)

 

(1,995,065)

 

(1,589,544)

 

(1,496,298)

 

(1,192,158)

 

Sales Hedge - transfer to profit or loss - Braskem Idesa

 

17.4(a.ii)

 

59,834

 

 

 

44,875

 

 

 

Income tax on exchange variation - Braskem Idesa

 

 

 

581,304

 

476,518

 

435,978

 

357,389

     

 

 

2,223,114

 

(6,681,498)

 

2,561,596

 

(6,403,241)

     

 

               
 

Foreign subsidiaries currency translation adjustment

 

 

 

339,296

 

653,349

 

63,697

 

718,763

     

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

2,699,278

 

(6,441,530)

 

2,771,171

 

(6,080,207)

     

 

               

Items that will not be reclassified to profit or loss

 

 

               
 

Defined benefit plan actuarial loss, net of taxes

 

 

 

(4,119)

 

(849)

 

(4,119)

 

(849)

 

Post-employment plans - Health plan, net of taxes

 

 

 

 

 

(8,280)

 

-

 

(8,280)

     

 

               
 

Total

 

 

 

(4,119)

 

(9,129)

 

(4,119)

 

(9,129)

     

 

               

Total comprehensive income (loss) for the year

 

 

 

1,965,962

 

(3,690,470)

 

2,355,580

 

(3,087,616)

     

 

               

Attributable to:

 

 

               
 

Company's shareholders

 

 

 

2,355,580

 

(3,087,616)

       
 

Non-controlling interest in Braskem Idesa

 

 

 

(389,618)

 

(602,854)

       
     

 

 

 

 

 

       

Total comprehensive income (loss) for the year

 

 

 

1,965,962

 

(3,690,470)

       
                       
                       
                       
                 

 

 

Parent company

                 

2016

 

2015

     

Note

         

Basic and diluted

 

Basic and diluted

Profit (loss) per share attributable to the shareholders of the Company

 

27

             

Restated

of continued operations at the end of the year (R$)

 

 

               

(expressed in reais)

 

 

               
 

Earnings per share - common

 

 

         

(0.5562)

 

3.7708

 

Earnings per share - preferred shares class "A"

 

 

         

(0.5562)

 

3.7708

 

Earnings per share - preferred shares class "B"

 

 

         

 

 

0.6065

                       

 

 

The Management notes are an integral part of the financial statements.

 

4

 


 
 

Braskem S.A.

 

Statement of changes in equity

All amounts in thousands of reais

 

     

Consolidated (restated)

     

Attributed to shareholders' interest

         
             

Revenue reserves

             

Total

       
                     

Additional

 

Other

     

Retained

 

Braskem

 

Non-controlling

 

Total

         

Capital

 

Legal

 

Retention

 

dividends

 

comprehensive

 

Treasury

 

earnings

 

shareholders'

 

interest in

 

shareholders'

 

Note

 

Capital

 

reserve

 

reserve

 

of profits

 

proposed

 

income

 

shares

 

(losses)

 

interest

 

Braskem Idesa

 

equity

 

 

                                           

At January 1, 2015 - previously disclosed

 

 

8,043,222

 

232,430

 

71,542

 

394,121

 

270,517

 

(2,924,057)

 

(48,892)

 

 

 

6,038,883

 

(144,533)

 

5,894,350

Adjustment of restatement

2.4

 

 

 

 

 

 

 

 

 

 

 

(19,115)

 

 

 

(278,177)

 

(297,292)

 

 

 

(297,292)

Opening balance at January 1, 2015 (restated)

 

 

8,043,222

 

232,430

 

71,542

 

394,121

 

270,517

 

(2,943,172)

 

(48,892)

 

(278,177)

 

5,741,591

 

(144,533)

 

5,597,058

 

 

                                           

Comprehensive income for the year:

 

                                           

Profit for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,001,720

 

3,001,720

 

(241,531)

 

2,760,189

Exchange variation of foreign sales hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(6,403,241)

 

 

 

 

 

(6,403,241)

 

(278,257)

 

(6,681,498)

Fair value of cash flow hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(395,729)

 

 

 

 

 

(395,729)

 

(17,652)

 

(413,381)

Foreign subsidiaries currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

 

718,763

 

 

 

 

 

718,763

 

(65,414)

 

653,349

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,080,207)

 

 

 

3,001,720

 

(3,078,487)

 

(602,854)

 

(3,681,341)

 

 

                                           

Equity valuation adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Realization of additional property, plant and equipment price-level restatement, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(27,236)

 

 

 

27,236

 

 

 

 

 

 

Realization of deemed cost of jointly-controlled investment, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(966)

 

 

 

966

 

 

 

 

 

 

Actuarial loss with post-employment benefits, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(849)

 

 

 

 

 

(849)

 

 

 

(849)

Post-employment plans - Health plan, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(8,280)

 

 

 

 

 

(8,280)

 

 

 

(8,280)

 

 

 

 

 

 

 

 

 

 

 

 

 

(37,331)

 

 

 

28,202

 

(9,129)

 

 

 

(9,129)

 

 

                                           

Contributions and distributions to shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital increase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

62,502

 

62,502

Repurchase of treasury shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(927)

 

 

 

(927)

 

 

 

(927)

Prescribed dividends

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

479

 

479

 

 

 

479

Additional dividends approved by the General Meeting

 

 

 

 

 

 

 

 

 

 

(270,517)

 

 

 

 

 

 

 

(270,517)

 

 

 

(270,517)

Legal reserve

 

 

 

 

 

 

158,450

 

 

 

 

 

 

 

 

 

(158,450)

 

 

 

 

 

 

Additional dividends proposed

 

 

 

 

 

 

 

 

 

 

247,364

 

 

 

 

 

(1,000,000)

 

(752,636)

 

 

 

(752,636)

Retained earnings

 

 

 

 

 

 

 

 

2,010,542

 

 

 

 

 

 

 

(2,010,542)

 

 

 

 

 

 

 

 

 

 

 

 

 

158,450

 

2,010,542

 

(23,153)

 

 

 

(927)

 

(3,168,513)

 

(1,023,601)

 

62,502

 

(961,099)

 

 

                                           

At December 31, 2015

 

 

8,043,222

 

232,430

 

229,992

 

2,404,663

 

247,364

 

(9,060,710)

 

(49,819)

 

(416,768)

 

1,630,374

 

(684,885)

 

945,489

 

 

                                           

Comprehensive income for the year:

                                             

Loss for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(411,472)

 

(411,472)

 

(317,725)

 

(729,197)

Exchange variation of foreign sales hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

2,561,596

 

 

 

 

 

2,561,596

 

(338,482)

 

2,223,114

Fair value of cash flow hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

145,878

 

 

 

 

 

145,878

 

(9,010)

 

136,868

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

 

63,697

 

 

 

 

 

63,697

 

275,599

 

339,296

 

 

 

 

 

 

 

 

 

 

 

 

 

2,771,171

 

 

 

(411,472)

 

2,359,699

 

(389,618)

 

1,970,081

 

 

                                           

Equity valuation adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Realization of additional property, plant and equipment price-level restatement, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(27,236)

 

 

 

27,236

 

 

 

 

 

 

Realization of deemed cost of jointly-controlled investment, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(965)

 

 

 

965

 

 

 

 

 

 

Actuarial gains post-employment benefits of subsidiaries , net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(4,119)

 

 

 

 

 

(4,119)

 

 

 

(4,119)

 

 

 

 

 

 

 

 

 

 

 

 

 

(32,320)

 

 

 

28,201

 

(4,119)

 

 

 

(4,119)

 

 

                                           

Contributions and distributions to shareholders:

26(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Absorption of losses and adjustments

 

 

 

 

 

 

 

 

(800,039)

 

 

 

 

 

 

 

800,039

 

 

 

 

 

 

Capital increase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

56,623

 

56,623

Additional dividends approved by the General Meeting

 

 

 

 

 

 

 

 

 

 

(247,364)

 

 

 

 

 

 

 

(247,364)

 

 

 

(247,364)

Interim dividends approved by Board of Directors

 

 

 

 

 

 

 

 

(1,000,000)

 

 

 

 

 

 

 

 

 

(1,000,000)

 

 

 

(1,000,000)

 

 

 

 

 

 

 

 

 

(1,800,039)

 

(247,364)

 

 

 

 

 

800,039

 

(1,247,364)

 

56,623

 

(1,190,741)

 

 

                                           

At December 31, 2016

 

 

8,043,222

 

232,430

 

229,992

 

604,624

 

 

 

(6,321,859)

 

(49,819)

 

 

 

2,738,590

 

(1,017,880)

 

1,720,710

 

The Management notes are an integral part of the financial statements.

 

5

 


 
 

Braskem S.A.

 

Statement of changes in equity

All amounts in thousands of reais

Continued

 

     

Parent Company (restated)

             

Revenue reserves

 

             
                     

Additional

 

Other

     

Retained

 

Total

         

Capital

 

Legal

 

Retention

 

dividends

 

comprehensive

 

Treasury

 

earnings

 

shareholders'

 

Note

 

Capital

 

reserve

 

reserve

 

of profits

 

proposed

 

income

 

shares

 

(losses)

 

equity

                                       

At January 1, 2015 - previously disclosed

 

 

8,043,222

 

232,430

 

71,542

 

394,121

 

270,517

 

(2,924,057)

 

 

 

 

 

6,087,775

Adjustment of restatement

2.4

 

 

 

 

 

 

 

 

 

 

 

(19,115)

 

 

 

(278,177)

 

(297,292)

Opening balance at January 1, 2015 (restated)

 

 

8,043,222

 

232,430

 

71,542

 

394,121

 

270,517

 

(2,943,172)

 

 

 

(278,177)

 

5,790,483

 

 

                                   

Comprehensive income for the year:

 

                                   

Profit for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,001,720

 

3,001,720

Exchange variation of foreign sales hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(6,403,241)

 

 

 

 

 

(6,403,241)

Fair value of cash flow hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(395,729)

 

 

 

 

 

(395,729)

Foreign subsidiaries currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

 

718,763

 

 

 

 

 

718,763

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,080,207)

 

 

 

3,001,720

 

(3,078,487)

 

 

                       

 

         

Equity valuation adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Realization of additional property, plant and equipment price-level restatement, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(966)

 

 

 

966

 

 

Realization of deemed cost of jointly-controlled investment, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(27,236)

 

 

 

27,236

 

 

Actuarial loss with post-employment benefits, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(849)

 

 

 

 

 

(849)

Post-employment plans - Health plan, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(8,280)

 

 

 

 

 

(8,280)

 

 

 

 

 

 

 

 

 

 

 

 

 

(37,331)

 

 

 

28,202

 

(9,129)

 

 

                   

 

 

 

         

Contributions and distributions to shareholders:

 

                                   

Repurchase of treasury shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(927)